Dr Charles Stacey has over 20 years of experience in healthcare; working as a healthcare provider, executive, entrepreneur, and investor. He has been the CEO and President of Cerecin since Feb 2015. Prior to joining Cerecin, he was with Inventages, a Nestle affiliated venture capital and private equity group, with $1.5 billion under management. At Inventages, he supported the neuroscience, digital health and Asia interest. Prior to Inventages, Charles worked in venture capital in the USA, for a neuro-medical device company and ran an orthopaedics medical device company that spun out of his surgical practice.  

Charles originally trained and practiced as a trauma and reconstructive surgeon at King’s College London. He is a member of the Royal College of Surgeons and General Medical Council, UK. Charles serves on the Board of Governors for Medical Affairs and as an advisor and investor in several life science companies. His undergraduate degree and research were in neuroscience at University College London and his Masters in Surgical Technology at ³Ô¹ÏºÚÁÏ College.